John P. Butler's Net Worth
$4.72 Million
Who is John P. Butler?
John P. Butler has an estimated net worth of $4.72 Million. This is based on reported shares across multiple companies, which include Akebia Therapeutics, Inc., Relypsa Inc, Zynerba Pharmaceuticals, Inc., and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
John P. Butler's CIK is 0001591467
Past Insider Trading and Trends
2014 was John P. Butler's most active year for acquiring shares with 9 total transactions. John P. Butler's most active month to acquire stocks was the month of May. 2016 was John P. Butler's most active year for disposing of shares, totalling 9 transactions. John P. Butler's most active month to dispose stocks was the month of February. 2017 saw John P. Butler paying a total of $1,936,000.00 for 369,500 shares, this is the most they've acquired in one year. In 2018 John P. Butler cashed out on 235,697 shares for a total of $1,213,131.18, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.65
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.23% | -46.57K |
$1.58 | -$73,580.60 | 2.04M |
Feb 29
| |||
Form 4
| -1.77% | -37.73K |
$1.52 | -$57,354.16 | 2.09M |
Feb 27
| |||
Form 4
| +35.44% | 557.01K |
$1.68 | -$78,101.52 | 2.13M |
Jan 31 - Feb 1
| |||
Form 4
| -5.53% | -91.87K |
$0.88 | -$80,614.17 | 1.57M |
Mar 1
| |||
Form 4
| -2.27% | -38.63K |
$0.81 | -$31,415.54 | 1.66M |
Feb 27
| |||
Form 4
| +20.84% | 293.13K |
—
|
—
| 1.7M |
Jan 31
| |||
Form 4
| +18.00% | 214.1K |
$2.17 | -$171,143.40 | 1.4M |
Feb 28 - Mar 1
| |||
Form 4/A
| +0.33% | 1.25K |
—
|
—
| 375.87K |
Dec 12
| |||
Form 4
| -0.36% | -4.11K |
$3.40 | -$13,970.60 | 1.15M |
Apr 1
| |||
Form 4
| +3.54% | 39.52K |
—
|
—
| 1.16M |
Mar 16
| |||
Form 4
| +20.17% | 187.41K |
$3.40 | -$169,771.04 | 1.12M |
Feb 26 - Mar 1
| |||
Form 4
| +30.08% | 237.4K |
—
|
—
| 1.03M |
Feb 28
| |||
Form 4
| +5.97% | 50K |
$3.44 | $172,000.00 | 887.73K |
Nov 20
| |||
Form 4
| +52.25% | 287K |
$0.47 | $134,890.00 | 836.23K |
Jun 3
| |||
Form 4
| +63.89% | 239.5K |
—
|
—
| 614.38K |
Feb 28
| |||
Form 4
| -26.59% | -135.70K |
$8.94 | -$1,213,131.18 | 374.62K |
Dec 12
| |||
Form 4
| +24.37% | 100K |
$0.47 | $47,000.00 | 510.31K |
Jul 11
| |||
Form 4
| +27.79% | 88.9K |
—
|
—
| 408.81K |
Feb 28
| |||
Form 4
| +60.27% | 119.5K |
—
|
—
| 317.78K |
Feb 21
| |||
Form 4
| +5.66% | 20K |
$0.47 | $9,400.00 | 373.48K |
Jan 19
| |||
Form 4
| +55.61% | 125.5K |
—
|
—
| 351.17K |
Feb 22
| |||
Form 4
| +12.46% | 25K |
$0.47 | $11,750.00 | 225.67K |
Jan 15
| |||
Form 4
| +33.70% | 50K |
$0.47 | $23,500.00 | 198.35K |
May 26
| |||
Form 4
| +206.83% | 100K |
$0.47 | $47,000.00 | 148.35K |
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
| +2.11% | 1K |
$11.57 | $11,567.20 | 48.35K |
Scheduled
|
Dec 29
| ||
Form 4
| +2.16% | 1K |
$11.92 | $11,916.00 | 47.35K |
Scheduled
|
Dec 22
| ||
Form 4
| +2.21% | 1K |
$11.34 | $11,336.40 | 46.35K |
Scheduled
|
Dec 15
| ||
Form 4
| +227.44% | 31.5K |
$0.78 | $24,640.00 | 45.35K |
Nov 11 - Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
∞
| 13.85K |
$17.00 | $235,450.00 | 13.85K |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Relypsa Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.10K |
$32.00 | -$163,168.00 |
0
|
Sep 1
| |||
Form 4
| +78.98% | 2.25K |
—
|
—
| 5.1K |
Jun 21
| |||
Form 4
| -26.23% | -1.01K |
$19.32 | -$19,570.35 | 2.85K |
Jun 7
| |||
Form 4
| -22.17% | -1.10K |
$34.62 | -$38,086.51 | 3.86K |
Scheduled
|
Jun 11
| ||
Form 4
| +82.96% | 2.25K |
—
|
—
| 4.96K |
Jun 4
| |||
Form 4
|
∞
| 2.71K |
—
|
—
| 2.71K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zynerba Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -80.77K |
—
|
—
|
0
|
Oct 10
| |||
Form 4
| +144.33% | 47.71K |
$0.35 | -$40.03 | 80.77K |
Jun 13 - Jun 14
| |||
Form 4
| +230.56% | 23.06K |
$1.01 | -$53.53 | 33.06K |
Jun 14
| |||
Form 4
| +100.00% | 5K |
—
|
—
| 10K |
Aug 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 5K |
$6.43 | $32,153.00 | 5K |
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KERYX BIOPHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 10K |
—
|
—
| 20K |
Jun 9
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
May 26
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||